Elucidation of a sialic acid metabolism pathway in mucus-foraging Ruminococcus gnavus unravels mechanisms of bacterial adaptation to the gut.


Journal

Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869

Informations de publication

Date de publication:
12 2019
Historique:
received: 20 04 2019
accepted: 12 09 2019
pubmed: 23 10 2019
medline: 1 7 2020
entrez: 23 10 2019
Statut: ppublish

Résumé

Sialic acid (N-acetylneuraminic acid (Neu5Ac)) is commonly found in the terminal location of colonic mucin glycans where it is a much-coveted nutrient for gut bacteria, including Ruminococcus gnavus. R. gnavus is part of the healthy gut microbiota in humans, but it is disproportionately represented in diseases. There is therefore a need to understand the molecular mechanisms that underpin the adaptation of R. gnavus to the gut. Previous in vitro research has demonstrated that the mucin-glycan-foraging strategy of R. gnavus is strain dependent and is associated with the expression of an intramolecular trans-sialidase, which releases 2,7-anhydro-Neu5Ac, rather than Neu5Ac, from mucins. Here, we unravelled the metabolism pathway of 2,7-anhydro-Neu5Ac in R. gnavus that is underpinned by the exquisite specificity of the sialic transporter for 2,7-anhydro-Neu5Ac and by the action of an oxidoreductase that converts 2,7-anhydro-Neu5Ac into Neu5Ac, which then becomes a substrate of a Neu5Ac-specific aldolase. Having generated an R. gnavus nan-cluster deletion mutant that lost the ability to grow on sialylated substrates, we showed that-in gnotobiotic mice colonized with R. gnavus wild-type (WT) and mutant strains-the fitness of the nan mutant was significantly impaired, with a reduced ability to colonize the mucus layer. Overall, we revealed a unique sialic acid pathway in bacteria that has important implications for the spatial adaptation of mucin-foraging gut symbionts in health and disease.

Identifiants

pubmed: 31636419
doi: 10.1038/s41564-019-0590-7
pii: 10.1038/s41564-019-0590-7
pmc: PMC6881182
mid: EMS84365
doi:

Substances chimiques

Glycoproteins 0
Mucins 0
Polysaccharides 0
Recombinant Proteins 0
2,7-anhydro-N-acetylneuraminic acid 95574-95-1
trans-sialidase EC 3.2.1.-
Neuraminidase EC 3.2.1.18
Oxo-Acid-Lyases EC 4.1.3.-
N-acetylneuraminate lyase EC 4.1.3.3
N-Acetylneuraminic Acid GZP2782OP0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2393-2404

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/P008895/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/00044452
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/000PR10353
Pays : United Kingdom

Références

Donaldson, G. P., Lee, S. M. & Mazmanian, S. K. Gut biogeography of the bacterial microbiota. Nat. Rev. Microbiol. 14, 20–32 (2016).
doi: 10.1038/nrmicro3552 pubmed: 26499895
Johansson, M. E. V., Larsson, J. M. H. & Hansson, G. C. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl Acad. Sci. USA 108, 4659–4665 (2011).
pubmed: 20615996 doi: 10.1073/pnas.1006451107
Etienne-Mesmin, L. et al. Experimental models to study intestinal microbes-mucus interactions in health and disease. FEMS Microbiol. Rev. 43, 457–489 (2019).
pubmed: 31162610 doi: 10.1093/femsre/fuz013
Jensen, P. H., Kolarich, D. & Packer, N. H. Mucin-type O-glycosylation—putting the pieces together. FEBS J. 277, 81–94 (2010).
pubmed: 19919547 doi: 10.1111/j.1742-4658.2009.07429.x
Ndeh, D. & Gilbert, H. J. Biochemistry of complex glycan depolymerisation by the human gut microbiota. FEMS Microbiol. Rev. 42, 146–164 (2018).
pubmed: 29325042 doi: 10.1093/femsre/fuy002
Tailford, L. E., Crost, E. H., Kavanaugh, D. & Juge, N. Mucin glycan foraging in the human gut microbiome. Front. Genet. 6, 81 (2015).
pubmed: 25852737 pmcid: 4365749 doi: 10.3389/fgene.2015.00081
Martens, E. C., Chiang, H. C. & Gordon, J. I. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe 4, 447–457 (2008).
pubmed: 18996345 pmcid: 2605320 doi: 10.1016/j.chom.2008.09.007
Robbe, C., Capon, C., Coddeville, B. & Michalski, J. C. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem. J. 384, 307–316 (2004).
pubmed: 15361072 pmcid: 1134114 doi: 10.1042/BJ20040605
Robbe, C. et al. Evidence of regio-specific glycosylation in human intestinal mucins—presence of an acidic gradient along the intestinal tract. J. Biol. Chem. 278, 46337–46348 (2003).
pubmed: 12952970 doi: 10.1074/jbc.M302529200
Juge, N., Tailford, L. & Owen, C. D. Sialidases from gut bacteria: a mini-review. Biochem. Soc. Trans. 44, 166–175 (2016).
pubmed: 26862202 pmcid: 4747158 doi: 10.1042/BST20150226
Lewis, A. L. & Lewis, W. G. Host sialoglycans and bacterial sialidases: a mucosal perspective. Cell. Microbiol. 14, 1174–1182 (2012).
doi: 10.1111/j.1462-5822.2012.01807.x pubmed: 22519819
Almagro-Moreno, S. & Boyd, E. F. Insights into the evolution of sialic acid catabolism among bacteria. BMC Evol. Biol. 9, 118 (2009).
pubmed: 19470179 pmcid: 2693436 doi: 10.1186/1471-2148-9-118
Plumbridge, J. & Vimr, E. Convergent pathways for utilization of the amino sugars N-acetylglucosamine, N-acetylmannosamine, and N-acetylneuraminic acid by Escherichia coli. J. Bacteriol. 181, 47–54 (1999).
pubmed: 9864311 pmcid: 103530 doi: 10.1128/JB.181.1.47-54.1999
Martinez, J., Steenbergen, S. & Vimr, E. Derived structure of the putative sialic acid transporter from Escherichia coli predicts a novel sugar permease domain. J. Bacteriol. 177, 6005–6010 (1995).
pubmed: 7592358 pmcid: 177433 doi: 10.1128/jb.177.20.6005-6010.1995
Brigham, C. et al. Sialic acid (N-acetyl neuraminic acid) utilization by Bacteroides fragilis requires a novel N-acetyl mannosamine epimerase. J. Bacteriol. 191, 3629–3638 (2009).
pubmed: 19304853 pmcid: 2681899 doi: 10.1128/JB.00811-08
Vimr, E. R., Kalivoda, K. A., Deszo, E. L. & Steenbergen, S. M. Diversity of microbial sialic acid metabolism. Microbiol. Mol. Biol. Rev. 68, 132–153 (2004).
pubmed: 15007099 pmcid: 362108 doi: 10.1128/MMBR.68.1.132-153.2004
Thomas, G. H. Sialic acid acquisition in bacteria—one substrate, many transporters. Biochem. Soc. Trans. 44, 760–765 (2016).
pubmed: 27284039 doi: 10.1042/BST20160056
Mulligan, C. et al. The substrate-binding protein imposes directionality on an electrochemical sodium gradient-driven TRAP transporter. Proc. Natl Acad. Sci. USA 106, 1778–1783 (2009).
pubmed: 19179287 doi: 10.1073/pnas.0809979106 pmcid: 2644114
Wahlgren, W. Y. et al. Substrate-bound outward-open structure of a Na
pubmed: 29717135 pmcid: 5931594 doi: 10.1038/s41467-018-04045-7
Severi, E., Hosie, A. H., Hawkhead, J. A. & Thomas, G. H. Characterization of a novel sialic acid transporter of the sodium solute symporter (SSS) family and in vivo comparison with known bacterial sialic acid transporters. FEMS Microbiol. Lett. 304, 47–54 (2010).
pubmed: 20100283 doi: 10.1111/j.1574-6968.2009.01881.x
Gangi Setty, T., Cho, C., Govindappa, S., Apicella, M. A. & Ramaswamy, S. Bacterial periplasmic sialic acid-binding proteins exhibit a conserved binding site. Acta Crystallogr. D 70, 1801–1811 (2014).
pubmed: 25004958 doi: 10.1107/S139900471400830X pmcid: 4089482
Mulligan, C., Leech, A. P., Kelly, D. J. & Thomas, G. H. The membrane proteins SiaQ and SiaM form an essential stoichiometric complex in the sialic acid tripartite ATP-independent periplasmic (TRAP) transporter SiaPQM (VC1777-1779) from Vibrio cholerae. J. Biol. Chem. 287, 3598–3608 (2012).
pubmed: 22167185 doi: 10.1074/jbc.M111.281030
Muller, A. et al. Conservation of structure and mechanism in primary and secondary transporters exemplified by SiaP, a sialic acid binding virulence factor from Haemophilus influenzae. J. Biol. Chem. 281, 22212–22222 (2006).
pubmed: 16702222 doi: 10.1074/jbc.M603463200
Severi, E. et al. Sialic acid transport in Haemophilus influenzae is essential for lipopolysaccharide sialylation and serum resistance and is dependent on a novel tripartite ATP-independent periplasmic transporter. Mol. Microbiol. 58, 1173–1185 (2005).
pubmed: 16262798 doi: 10.1111/j.1365-2958.2005.04901.x
Post, D. M., Mungur, R., Gibson, B. W. & Munson, R. S. Jr. Identification of a novel sialic acid transporter in Haemophilus ducreyi. Infect. Immun. 73, 6727–6735 (2005).
pubmed: 16177350 pmcid: 1230923 doi: 10.1128/IAI.73.10.6727-6735.2005
North, R. A. et al. The sodium sialic acid symporter from Staphylococcus aureus has altered substrate specificity. Front. Chem. 6, 233 (2018).
pubmed: 30023356 pmcid: 6039549 doi: 10.3389/fchem.2018.00233
Hopkins, A. P., Hawkhead, J. A. & Thomas, G. H. Transport and catabolism of the sialic acids N-glycolylneuraminic acid and 3-keto-3-deoxy-D-glycero-D-galactonononic acid by Escherichia coli K-12. FEMS Microbiol. Lett. 347, 14–22 (2013).
pubmed: 23848303 doi: 10.1111/1574-6968.12213
Sagheddu, V., Patrone, V., Miragoli, F., Puglisi, E. & Morelli, L. Infant early gut colonization by Lachnospiraceae: high frequency of Ruminococcus gnavus. Front. Pediatr. 4, 57 (2016).
pubmed: 27313996 pmcid: 4889575 doi: 10.3389/fped.2016.00057
Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).
pubmed: 20203603 pmcid: 3779803 doi: 10.1038/nature08821
Ludwig, W., Schleifer, K.-H. & Whitman, W. B. in Bergey’s Manual of Systematic Bacteriology Vol. 3 (eds De Vos, P. et al.) 1–13 (Springer, 2009).
Kraal, L., Abubucker, S., Kota, K., Fischbach, M. A. & Mitreva, M. The prevalence of species and strains in the human microbiome: a resource for experimental efforts. PLoS ONE 9, e97279 (2014).
pubmed: 24827833 pmcid: 4020798 doi: 10.1371/journal.pone.0097279
Olbjorn, C. et al. Fecal microbiota profiles in treatment-naive pediatric inflammatory bowel disease—associations with disease phenotype, treatment, and outcome. Clin. Exp. Gastroenterol. 12, 37–49 (2019).
pubmed: 30774408 pmcid: 6362922 doi: 10.2147/CEG.S186235
Sokol, H. et al. Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection. Gut Microbes 9, 55–60 (2018).
pubmed: 28786749 doi: 10.1080/19490976.2017.1361092
Nishino, K. et al. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. J. Gastroenterol. 53, 95–106 (2018).
pubmed: 28852861 doi: 10.1007/s00535-017-1384-4
Machiels, K. et al. Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Gut 66, 79–88 (2017).
pubmed: 26423113 doi: 10.1136/gutjnl-2015-309398
Hall, A. B. et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med. 9, 103 (2017).
pubmed: 29183332 pmcid: 5704459 doi: 10.1186/s13073-017-0490-5
Fuentes, S. et al. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation. ISME J. 11, 1877–1889 (2017).
pubmed: 28398347 pmcid: 5520032 doi: 10.1038/ismej.2017.44
Joossens, M. et al. Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut 60, 631–637 (2011).
pubmed: 21209126 doi: 10.1136/gut.2010.223263
Willing, B. P. et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139, 1844–1854 (2010).
pubmed: 20816835 doi: 10.1053/j.gastro.2010.08.049
Png, C. W. et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105, 2420–2428 (2010).
pubmed: 20648002 doi: 10.1038/ajg.2010.281
Owen, C. D. et al. Unravelling the specificity and mechanism of sialic acid recognition by the gut symbiont Ruminococcus gnavus. Nat. Commun. 8, 2196 (2017).
pubmed: 29259165 pmcid: 5736709 doi: 10.1038/s41467-017-02109-8
Monaco, S., Tailford, L. E., Juge, N. & Angulo, J. Differential epitope mapping by STD NMR spectroscopy to reveal the nature of protein-ligand contacts. Angew. Chem. Int. Edn 56, 15289–15293 (2017).
doi: 10.1002/anie.201707682
Crost, E. H. et al. The mucin-degradation strategy of Ruminococcus gnavus: the importance of intramolecular trans-sialidases. Gut Microbes 7, 302–312 (2016).
pubmed: 27223845 pmcid: 4988440 doi: 10.1080/19490976.2016.1186334
Tailford, L. E. et al. Discovery of intramolecular trans-sialidases in human gut microbiota suggests novel mechanisms of mucosal adaptation. Nat. Commun. 6, 7624 (2015).
pubmed: 26154892 doi: 10.1038/ncomms8624
Crost, E. H. et al. Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependent. PLoS ONE 8, e76341 (2013).
pubmed: 24204617 pmcid: 3808388 doi: 10.1371/journal.pone.0076341
Monestier, M. et al. Membrane-enclosed multienzyme (MEME) synthesis of 2,7-anhydro-sialic acid derivatives. Carbohydr. Res. 451, 110–117 (2017).
pubmed: 28851488 pmcid: 5667892 doi: 10.1016/j.carres.2017.08.008
Xu, G. et al. Three Streptococcus pneumoniae sialidases: three different products. J. Am. Chem. Soc. 133, 1718–1721 (2011).
pubmed: 21244006 doi: 10.1021/ja110733q
Xu, G. et al. Crystal structure of the NanB sialidase from Streptococcus pneumoniae. J. Mol. Biol. 384, 436–449 (2008).
pubmed: 18835278 doi: 10.1016/j.jmb.2008.09.032
Kumar, J. P., Rao, H., Nayak, V. & Ramaswamy, S. Crystal structures and kinetics of N-acetylneuraminate lyase from Fusobacterium nucleatum. Acta Crystallogr. F 74, 725–732 (2018).
doi: 10.1107/S2053230X18012992
Campeotto, I. et al. Pathological macromolecular crystallographic data affected by twinning, partial-disorder and exhibiting multiple lattices for testing of data processing and refinement tools. Sci. Rep. 8, 14876 (2018).
pubmed: 30291262 pmcid: 6173773 doi: 10.1038/s41598-018-32962-6
North, R. A. et al. Structure and inhibition of N-acetylneuraminate lyase from methicillin-resistant Staphylococcus aureus. FEBS Lett. 590, 4414–4428 (2016).
pubmed: 27943302 doi: 10.1002/1873-3468.12462
Timms, N. et al. Structural insights into the recovery of aldolase activity in N-acetylneuraminic acid lyase by replacement of the catalytically active lysine with γ-thialysine by using a chemical mutagenesis strategy. ChemBioChem 14, 474–481 (2013).
pubmed: 23418011 pmcid: 3792637 doi: 10.1002/cbic.201200714
Huynh, N. et al. Structural basis for substrate specificity and mechanism of N-acetyl-D-neuraminic acid lyase from Pasteurella multocida. Biochemistry 52, 8570–8579 (2013).
pubmed: 24152047 doi: 10.1021/bi4011754
Barbosa, J. A. et al. Active site modulation in the N-acetylneuraminate lyase sub-family as revealed by the structure of the inhibitor-complexed Haemophilus influenzae enzyme. J. Mol. Biol. 303, 405–421 (2000).
pubmed: 11031117 doi: 10.1006/jmbi.2000.4138
Daniels, A. D. et al. Reaction mechanism of N-acetylneuraminic acid lyase revealed by a combination of crystallography, QM/MM simulation, and mutagenesis. ACS Chem. Biol. 9, 1025–1032 (2014).
pubmed: 24521460 pmcid: 4004234 doi: 10.1021/cb500067z
Heap, J. T. et al. The ClosTron: mutagenesis in Clostridium refined and streamlined. J. Microbiol. Methods 80, 49–55 (2010).
pubmed: 19891996 doi: 10.1016/j.mimet.2009.10.018
Mandal, C., Schwartz-Albiez, R. & Vlasak, R. in Sialoglyco Chemistry and Biology I: Biosynthesis, Structural Diversity and Sialoglycopathologies Vol. 366 (eds Gerardy-Schahn, R. et al.) 1–30 (Springer, 2015).
Vimr, E. R. Unified theory of bacterial sialometabolism: how and why bacteria metabolize host sialic acids. ISRN Microbiol. 2013, 816713 (2013).
pubmed: 23724337 pmcid: 3658417 doi: 10.1155/2013/816713
Robbe-Masselot, C., Maes, E., Rousset, M., Michalski, J. C. & Capon, C. Glycosylation of human fetal mucins: a similar repertoire of O-glycans along the intestinal tract. Glycoconj. J. 26, 397–413 (2009).
pubmed: 18807179 doi: 10.1007/s10719-008-9186-9
Pezzicoli, A., Ruggiero, P., Amerighi, F., Telford, J. L. & Soriani, M. Exogenous sialic acid transport contributes to group B Streptococcus infection of mucosal surfaces. J. Infect. Dis. 206, 924–931 (2012).
pubmed: 22829646 doi: 10.1093/infdis/jis451
Bidossi, A. et al. A functional genomics approach to establish the complement of carbohydrate transporters in Streptococcus pneumoniae. PLoS ONE 7, e33320 (2012).
pubmed: 22428019 pmcid: 3302838 doi: 10.1371/journal.pone.0033320
Marion, C., Burnaugh, A. M., Woodiga, S. A. & King, S. J. Sialic acid transport contributes to pneumococcal colonization. Infect. Immun. 79, 1262–1269 (2011).
pubmed: 21189320 doi: 10.1128/IAI.00832-10
Gangi Setty, T. et al. Molecular characterization of the interaction of sialic acid with the periplasmic binding protein from Haemophilus ducreyi. J. Biol. Chem. 293, 20073–20084 (2018).
pubmed: 30315109 doi: 10.1074/jbc.RA118.005151 pmcid: 6311513
Xiao, A. et al. Streptococcus pneumoniae sialidase SpNanB-catalyzed one-pot multienzyme (OPME) synthesis of 2,7-anhydro-sialic acids as selective sialidase inhibitors. J. Org. Chem. 83, 10798–10804 (2018).
pubmed: 30105908 pmcid: 6327951 doi: 10.1021/acs.joc.8b01519
Duncan, S. H., Hold, G. L., Harmsen, H. J., Stewart, C. S. & Flint, H. J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 52, 2141–2146 (2002).
pubmed: 12508881
Liu, H. & Naismith, J. H. A simple and efficient expression and purification system using two newly constructed vectors. Protein Expr. Purif. 63, 102–111 (2009).
pubmed: 18845260 doi: 10.1016/j.pep.2008.09.008
Gerlt, J. A. et al. Enzyme Function Initiative-Enzyme Similarity Tool (EFI-EST): a web tool for generating protein sequence similarity networks. Biochim. Biophys. Acta 1854, 1019–1037 (2015).
pubmed: 25900361 pmcid: 4457552 doi: 10.1016/j.bbapap.2015.04.015
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
pubmed: 14597658 pmcid: 403769 doi: 10.1101/gr.1239303
Medema, M. H., Takano, E. & Breitling, R. Detecting sequence homology at the gene cluster level with MultiGeneBlast. Mol. Biol. Evol. 30, 1218–1223 (2013).
pubmed: 23412913 pmcid: 3670737 doi: 10.1093/molbev/mst025
Owen, C. D. et al. Streptococcus pneumoniae NanC: structural insights into the specificity and mechanism of a sialidase that produces a sialidase inhibitor. J. Biol. Chem. 290, 27736–27748 (2015).
pubmed: 26370075 pmcid: 4646021 doi: 10.1074/jbc.M115.673632
Perutka, J., Wang, W., Goerlitz, D. & Lambowitz, A. M. Use of computer-designed group II introns to disrupt Escherichia coli DExH/D-box protein and DNA helicase genes. J. Mol. Biol. 336, 421–439 (2004).
pubmed: 14757055 doi: 10.1016/j.jmb.2003.12.009
Mayer, M. & Meyer, B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Edn 38, 1784–1788 (1999).
doi: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q
Hwang, T. L. & Shaka, A. J. Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. A 112, 275–279 (1995).
doi: 10.1006/jmra.1995.1047
Nepravishta, R., Walpole, S., Tailford, L., Juge, N. & Angulo, J. Deriving ligand orientation in weak protein-ligand complexes by DEEP-STD NMR spectroscopy in the absence of protein chemical-shift assignment. ChemBioChem 20, 340–344 (2019).
pubmed: 30379391 doi: 10.1002/cbic.201800568
Mayer, M. & James, T. L. NMR-based characterization of phenothiazines as a RNA binding scaffold. J. Am. Chem. Soc. 126, 4453–4460 (2004).
pubmed: 15053636 doi: 10.1021/ja0398870
Sanchez-Weatherby, J. et al. VMXi: a fully automated, fully remote, high-flux in situ macromolecular crystallography beamline. J. Synchrotron Radiat. 26, 291–301 (2019).
pubmed: 30655497 pmcid: 6337891 doi: 10.1107/S1600577518015114
Krissinel, E., Uski, V., Lebedev, A., Winn, M. & Ballard, C. Distributed computing for macromolecular crystallography. Acta Crystallogr. D 74, 143–151 (2018).
doi: 10.1107/S2059798317014565
Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. D 66, 22–25 (2010).
pubmed: 20057045 doi: 10.1107/S0907444909042589
Keegan, R. M. & Winn, M. D. MrBUMP: an automated pipeline for molecular replacement. Acta Crystallogr. D 64, 119–124 (2008).
pubmed: 18094475 doi: 10.1107/S0907444907037195
van Beusekom, B., Joosten, K., Hekkelman, M. L., Joosten, R. P. & Perrakis, A. Homology-based loop modelling yields more complete crystallographic protein structures. IUCr 5, 585–594 (2018).
doi: 10.1107/S2052252518010552
Emsley, P. Tools for ligand validation in Coot. Acta Crystallogr. D 73, 203–210 (2017).
doi: 10.1107/S2059798317003382
Smart, O. S. et al. Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER. Acta Crystallogr. D 68, 368–380 (2012).
pubmed: 22505257 doi: 10.1107/S0907444911056058 pmcid: 3322596
Langer, G., Cohen, S. X., Lamzin, V. S. & Perrakis, A. Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat. Protoc. 3, 1171–1179 (2008).
pubmed: 18600222 pmcid: 2582149 doi: 10.1038/nprot.2008.91
Winn, M. D., Murshudov, G. N. & Papiz, M. Z. Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol. 374, 300–321 (2003).
pubmed: 14696379 doi: 10.1016/S0076-6879(03)74014-2
Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018).
pubmed: 29067766 doi: 10.1002/pro.3330
McCoy, A. J. et al. Gyre and gimble: a maximum-likelihood replacement for Patterson correlation refinement. Acta Crystallogr. D 74, 279–289 (2018).
doi: 10.1107/S2059798318001353
Vonrhein, C. et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D 67, 293–302 (2011).
pubmed: 21460447 doi: 10.1107/S0907444911007773 pmcid: 3069744
STARANISO (Global Phasing Ltd., 2018); http://staraniso.globalphasing.org/cgi-bin/staraniso.cgi
Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
pubmed: 23618408 pmcid: 4053844 doi: 10.1186/gb-2013-14-4-r36
Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
pubmed: 20979621 pmcid: 3218662 doi: 10.1186/gb-2010-11-10-r106
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
pubmed: 22743772 doi: 10.1038/nmeth.2019

Auteurs

Andrew Bell (A)

The Gut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Jason Brunt (J)

The Gut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.

Emmanuelle Crost (E)

The Gut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Laura Vaux (L)

The Gut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Ridvan Nepravishta (R)

School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, UK.

C David Owen (CD)

Diamond Light Source, Harwell Science and Innovation Campus, Didcot, UK.
Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot, UK.

Dimitrios Latousakis (D)

The Gut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

An Xiao (A)

Department of Chemistry, University of California, Davis, Davis, CA, USA.

Wanqing Li (W)

Department of Chemistry, University of California, Davis, Davis, CA, USA.

Xi Chen (X)

Department of Chemistry, University of California, Davis, Davis, CA, USA.

Martin A Walsh (MA)

Diamond Light Source, Harwell Science and Innovation Campus, Didcot, UK.
Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot, UK.

Jan Claesen (J)

Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Jesus Angulo (J)

School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, UK.

Gavin H Thomas (GH)

Department of Biology, University of York, York, UK.

Nathalie Juge (N)

The Gut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK. nathalie.juge@quadram.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH